The efficacy and adverse effects of anlotinib in the treatment of high-grade glioma: a retrospective analysis
- Type
- Retraction
- Notice date
- 2/20/2024 0:00
- Journal
- Frontiers in Oncology
- Publisher
- Frontiers
- Notice DOI
- 10.3389/fonc.2024.1383410
- Original paper DOI
- 10.3389/fonc.2023.1095362
Reasons
- Concerns/Issues about Results and/or Conclusions
- Concerns/Issues about Third Party Involvement
- Concerns/Issues about Peer Review
- Compromised Peer Review
- Investigation by Journal/Publisher
- Paper Mill
- Unreliable Results and/or Conclusions